inflammatory%20bowel%20disease
INFLAMMATORY BOWEL DISEASE
Inflammatory bowel disease consists of ulcerative colitis and Crohn's disease.
Ulcerative colitis is a diffuse mucosal inflammation limited to the colon while Crohn's disease is a patchy, transmural inflammation that occurs in any part of the gastrointestinal tract.
The ileum and colon are the most frequently affected sites.

Introduction

  • Consists of ulcerative colitis (UC) and Crohn’s disease (CD)
    • UC: Diffuse mucosal inflammation limited to the colon
    • CD: Patchy, transmural inflammation that can occur in any part of the GI tract
      • Ileum and colon are the most frequently affected sites

Signs and Symptoms

General Symptoms

Depend on the segment of the intestinal tract involved

  • Chronic diarrhea or constipation
  • Abdominal pain and cramps
  • Blood in stool
  • Pain with bowel movement
  • Urgency in bowel movement
  • Tenesmus
  • Reduced appetite
  • Weight loss
  • Fever
  • Fatigue
  • Growth retardation
  • Primary amenorrhea
  • Night sweats

Clinical Features

Ulcerative Colitis (UC)

  • Cardinal symptoms: Bloody diarrhea, frequent, small volume
  • Associated symptoms: Colicky abdominal pain, tenesmus, urgency

Crohn's Disease (CD)

  • Chronic diarrhea, abdominal pain, weight loss
  • Abdominal mass, perianal lesions, stomatitis, fissures and fistulas
  • Malaise, fever, anorexia are more common with CD than UC

Risk Factors

Risk Factors

  • Smoking is a risk factor for CD but has a protective factor for UC through unknown mechanism
  • Age - most people are diagnosed between 15 and 35 years
  • UC is more common in men while CD is more frequent in women
  • Family history
  • Recent episodes of infectious gastroenteritis
Editor's Recommendations
Most Read Articles
20 Jul 2017
Patients with rheumatoid arthritis (RA) appear to have a high prevalence of any carotid plaques and severe carotid plaques, with high titre of anticyclic citrullinated peptide (anti-CCP) antibodies a risk factor for severe carotid atherosclerotic plaque in RA, according to a study.
22 Jun 2017
Compared with other models of care, nurse-led care (NLC) for patients with rheumatoid arthritis (RA) is effective, acceptable and safe, according to a recent study. However, current evidence is limited to draw conclusions on its accessibility, appropriateness and efficiency.
Tristan Manalac, 20 May 2017
Global postural re-education (GPR) can moderately improve pain and function in spinal disorders especially when performed during intermediate follow-ups instead of immediately after initial treatment, a new meta-analysis reports.
Dr. Joseph Delano Fule Robles, 23 Jun 2017

Vobarilizumab, a nanobody consisting of an anti-interleukin 6 (IL-6) receptor domain developed for the treatment of rheumatoid arthritis (RA), is shown to be safe and efficacious in RA patients with inadequate response to methotrexate in a study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held recently in Madrid, Spain.